by Catharina G. Faber
Neuromuscular Centre the Netherlands
The field of neuromuscular diseases in the Netherlands is characterized by a longstanding tradition of collaboration between seven neuromuscular centres of the university hospitals. This collaboration has been formalised since 1993, when… Continue Reading
News from the Journal editors:
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing–remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
The EAN congress quiz 2017 is online now until March 29:
Just log-in to “MyEAN” on the EAN website and click on
Congress Quiz 2017
Answer all questions correctly, and you participate in the raffle for 3 free congress registrations… Continue Reading
Dear EAN Individual Members,
Time seems to be passing very quickly and our next Congress, the best opportunity for enjoying your membership benefits, is just around the corner!
Before the early registration deadline, 29 March 2017, passes we would like… Continue Reading
On Thursday, 16 March 2017 a Memorandum of Understanding (MoU) was signed between the EAN and the AFAN. The signed MoU will be an important instrument of cooperation between the two societies.
18th March 2017: Three months left to the most important event for European Neurologists: the 3rd congress of the European Academy of Neurology is coming. Find out more at the congress website. Deadline for the early registration is 29th of… Continue Reading
A discussion paper about the Value of Treatment for Brain Disorders was released on 28 February 2017. The Value of Treatment for Brain Disorders (VoT) is a 2-year research project undertaken by EBC with the overall goal of assessing the treatment gaps and the cost of non-(or inadequate) treatments, and promoting a holistic healthcare approach (versus fragmentation and results in silo)
By Karin Klijn
Over the past three decades the diagnosis and treatment of stroke has seen tremendous changes, which have led to a complete change of clinical practice, probably best illustrated by the adagio “time is brain”.
Dutch researchers… Continue Reading
We would like to draw your attention to the Public Stakeholder Consultation – Evaluation of Public-Public Partnerships (PPP) in the context of the Horizon 2020 Interim Evaluation, that the scientific community is asked to contribute to.
You are particularly encouraged… Continue Reading
Early Registration Fee Deadline: March 23, 2017
The UEMS EBN Board examination will be held one day prior to the 3rd congress of the European Academy of Neurology.
Date: Friday, June 23, 2017
Venue: Europaplein 22, 1078 GZ Amsterdam, The… Continue Reading
Annual conference in multiple sclerosis: High-quality care for improved patient outcomes
ECTRIMS FOCUSED WORKSHOP - „Advancing Trial Design in Progressive Multiple Sclerosis (in association with the Progressive MS Alliance)”
4th International Porto Congress of Multiple Sclerosis
The 12th World Congress on Brain Injury
Report from Dr Madara Lazdane from Riga, Latvia visiting Department of Biomedical Science and Neuromotor - Clinical of Neurology, Bologna, Italy under the supervision of Prof. Pietro Cortelli
The new CME article March 2017: “A comprehensive assessment of cognitive function in the common genetic generalized epilepsy syndromes? is online now!
Please log-in and browse to the LEARN section on the EAN Website and answer the questions!
All e-learning… Continue Reading
The official Journal of the EAN *
Are you a member of the EAN or a member of a European National Neurological Society?
If so, you are likely to be eligible for FREE online access to the European Journal of… Continue Reading